Who Paid My Doc
Roberto Perez Roman
Neurological Surgery Arecibo, PR Medical Doctor
NPI 1265895973 CMS profile 8801872
Carretera 129, Km 1.0 Av. San Luis, Arecibo, PR 00613
General payments
$3,164
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Roberto Perez Roman of Arecibo, PR is reported in the CMS Open Payments database as having received $3,164 across 32 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 50th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $218 | 2 | |
| 2023 | General | $2,050 | 20 | |
| 2022 | General | $839 | 8 | |
| 2021 | General | $17 | 1 | |
| 2020 | General | $40 | 1 |
Beside peers
- Roberto Perez Roman
- Neurological Surgery median
- Middle half of Neurological Surgery
- National median
In program year 2025, general payments to Roberto Perez Roman were reported at $0. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.
Show as a table
| Year | Roberto Perez Roman | Neurological Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $582 | $138–$3,006 | $163 |
| 2020 | $40 | $294 | $76–$2,174 | $114 |
| 2021 | $17 | $387 | $105–$2,432 | $132 |
| 2022 | $839 | $542 | $139–$2,989 | $149 |
| 2023 | $2,050 | $534 | $145–$2,697 | $160 |
| 2024 | $218 | $574 | $155–$3,046 | $164 |
| 2025 | $0 | $596 | $159–$3,102 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 2 drugsPart D claims
54
Drug cost
$375
Branded share of claims
61.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 33 | $295 | |
| Tramadol Hcl | Generic | 21 | $80 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.
Records
32 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurological Surgery in Puerto Rico
Rafael Cardona Duran
Neurological Surgery · Guaynabo, PR
Rodolfo Alcedo
Neurological Surgery · San Juan, PR
David Lozada
Neurological Surgery · Manati, PR
Samuel Estronza-Ojeda
Neurological Surgery · Caguas, PR
Yadira Dacosta
Neurological Surgery · Humacao, PR
Rafael Rodriguez-Mercado
Neurological Surgery · San Juan, PR
Related records
Neurological Surgery in Puerto Rico
Practitioners in the same specialty and state, ranked by reported value.
All Neurological Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Puerto Rico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.